Reply to Biosimilars: A position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers'

dc.creator	Bakalos G., Schreitmüller T.	en
dc.date.accessioned	2023-01-31T07:35:16Z
dc.date.available	2023-01-31T07:35:16Z
dc.date.issued	2017
dc.identifier	10.1136/esmoopen-2017-000281
dc.identifier.issn	20597029
dc.identifier.uri	http://hdl.handle.net/11615/71057
dc.description.abstract	[No abstract available]	en
dc.language.iso	en	en
dc.source	ESMO Open	en
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048101352&doi=10.1136%2fesmoopen-2017-000281&partnerID=40&md5=a903ee55bceb23888c83d40893055063
dc.subject	BMJ Publishing Group	en
dc.title	Reply to Biosimilars: A position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers'	en
dc.type	other	en

Files in questo item

Files	Dimensione	Formato	Mostra
Nessun files in questo item.